Rauth A M, Chin J, Marchow L, Paciga J
Br J Cancer Suppl. 1978 Jun;3:202-5.
Use has been made of the transplantable KHT sarcoma in C3H mice to test the in vivo effectiveness of some 2-, 4-, and 5-nitroimidazoles as hypoxic cell radiosensitizers. A comparison of the in vivo versus the in vitro sensitizing ability of misonidazole and metronidazole indicates some differences, probably due to drug delivery problems in vivo. The relative sensitizing abilities of eight 2-nitroimidazoles, two 4-nigroimidazoles and two 5-nitroimidazoles are compared on the basis of the amount of drug injected and the plasma levels obtained.
利用C3H小鼠体内可移植的KHT肉瘤来测试一些2-、4-和5-硝基咪唑作为乏氧细胞放射增敏剂的体内有效性。米索硝唑和甲硝唑体内与体外增敏能力的比较表明存在一些差异,这可能是由于体内的药物递送问题所致。基于注射药物的量和所获得的血浆水平,对8种2-硝基咪唑、2种4-硝基咪唑和2种5-硝基咪唑的相对增敏能力进行了比较。